APA (7th ed.) Citation

Ye C, Zhu S, Yuan J, & Yuan X. (2024). FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization. Dove Medical Press.

Chicago Style (17th ed.) Citation

Ye C, Zhu S, Yuan J, and Yuan X. FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, Is Related to Disease Activity, Inflammation and Macrophage Polarization. Dove Medical Press, 2024.

MLA (9th ed.) Citation

Ye C, et al. FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, Is Related to Disease Activity, Inflammation and Macrophage Polarization. Dove Medical Press, 2024.